Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal
Go back to Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.87 +0.28 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.59 | 52 Week High | $77.12 | |||
| Open | $59.45 | 52 Week Low | $49.03 | |||
| Day High | $59.87 | P/E | 38.88 | |||
| Day Low | $59.01 | EPS | $1.54 | |||
| Volume | 2,089,800 | |||||
| TORREYPINES THERA (NASDAQ: TPTX) | Delayed: 76.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.01 | 52 Week High | $0.69 | |||
| Open | $0.10 | 52 Week Low | $0.07 | |||
| Day High | $76.01 | P/E | N/A | |||
| Day Low | $76.01 | EPS | $-0.90 | |||
| Volume | 11,307 | |||||



